PortfoliosLab logoPortfoliosLab logo
WW vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

WW vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WW International, Inc. (WW) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WW achieves a -45.30% return, which is significantly lower than NVO's -12.70% return. Over the past 10 years, WW has underperformed NVO with an annualized return of 0.55%, while NVO has yielded a comparatively higher 6.45% annualized return.


WW

1D
-4.77%
1M
49.77%
YTD
-45.30%
6M
-40.04%
1Y
6,302.24%
3Y*
30.50%
5Y*
-16.58%
10Y*
0.55%

NVO

1D
-2.61%
1M
-2.19%
YTD
-12.70%
6M
-6.35%
1Y
-38.32%
3Y*
-16.12%
5Y*
3.67%
10Y*
6.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WW vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
WW
WW International, Inc.
-45.30%2,200.39%-85.49%126.68%-76.07%-33.89%-36.14%-0.88%-12.94%286.72%
NVO
Novo Nordisk A/S
-12.70%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between WW and NVO is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2001

0.16

Fundamentals

Market Cap

WW:

$159.74M

NVO:

$190.94B

EPS

WW:

$38.75

NVO:

$27.42

PE Ratio

WW:

0.41

NVO:

1.57

PEG Ratio

WW:

0.00

NVO:

0.07

PS Ratio

WW:

0.64

NVO:

0.58

PB Ratio

WW:

0.60

NVO:

0.94

Total Revenue (TTM)

WW:

$691.42M

NVO:

$327.80B

Gross Profit (TTM)

WW:

$496.30M

NVO:

$268.30B

EBITDA (TTM)

WW:

$1.30B

NVO:

$181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WW vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WW
WW Risk / Return Rank: 9292
Overall Rank
WW Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
WW Sortino Ratio Rank: 100100
Sortino Ratio Rank
WW Omega Ratio Rank: 100100
Omega Ratio Rank
WW Calmar Ratio Rank: 100100
Calmar Ratio Rank
WW Martin Ratio Rank: 100100
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1414
Overall Rank
NVO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1313
Sortino Ratio Rank
NVO Omega Ratio Rank: 1111
Omega Ratio Rank
NVO Calmar Ratio Rank: 1515
Calmar Ratio Rank
NVO Martin Ratio Rank: 2020
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WW vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WW International, Inc. (WW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WWNVODifference

Sharpe ratio

Return per unit of total volatility

0.58

-0.74

+1.32

Sortino ratio

Return per unit of downside risk

273.39

-0.85

+274.23

Omega ratio

Gain probability vs. loss probability

32.58

0.88

+31.71

Calmar ratio

Return relative to maximum drawdown

104.29

-0.68

+104.97

Martin ratio

Return relative to average drawdown

177.17

-1.01

+178.18

WW vs. NVO - Sharpe Ratio Comparison

The current WW Sharpe Ratio is 0.58, which is higher than the NVO Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of WW and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WWNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.58

-0.74

+1.32

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.00

0.10

-0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.00

0.20

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.00

0.47

-0.47

Drawdowns

WW vs. NVO - Drawdown Comparison

The maximum WW drawdown since its inception was -99.87%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for WW and NVO.


Loading charts...

Drawdown Indicators


WWNVODifference

Max Drawdown

Largest peak-to-trough decline

-99.87%

-74.70%

-25.17%

Max Drawdown (1Y)

Largest decline over 1 year

-79.68%

-55.03%

-24.65%

Max Drawdown (3Y)

Largest decline over 3 years

-99.02%

-74.70%

-24.32%

Max Drawdown (5Y)

Largest decline over 5 years

-99.68%

-74.70%

-24.98%

Max Drawdown (10Y)

Largest decline over 10 years

-99.87%

-74.70%

-25.17%

Current Drawdown

Current decline from peak

-84.50%

-68.81%

-15.69%

Average Drawdown

Average peak-to-trough decline

-51.35%

-17.75%

-33.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.91%

36.77%

+10.14%

Volatility

WW vs. NVO - Volatility Comparison

WW International, Inc. (WW) has a higher volatility of 45.47% compared to Novo Nordisk A/S (NVO) at 7.70%. This indicates that WW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WWNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

45.47%

7.70%

+37.77%

Volatility (6M)

Calculated over the trailing 6-month period

72.26%

37.81%

+34.45%

Volatility (1Y)

Calculated over the trailing 1-year period

16,706.77%

51.76%

+16,655.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

7,233.54%

38.20%

+7,195.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

5,078.84%

32.49%

+5,046.35%

Dividends

WW vs. NVO - Dividend Comparison

WW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.20%.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
4.20%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
WW
WW International, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

WW vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between WW International, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
167.36M
96.82B
(WW) Total Revenue
(NVO) Total Revenue
Values in USD except per share items

WW vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between WW International, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%20222023202420252026
70.9%
86.0%
Portfolio components
WW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, WW International, Inc. reported a gross profit of 118.67M and revenue of 167.36M. Therefore, the gross margin over that period was 70.9%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

WW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, WW International, Inc. reported an operating income of 62.50M and revenue of 167.36M, resulting in an operating margin of 37.3%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

WW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, WW International, Inc. reported a net income of -52.00M and revenue of 167.36M, resulting in a net margin of -31.1%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


WW and NVO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WW has higher volatility (45.47%) compared to NVO (7.70%). In terms of maximum drawdown, WW dropped -99.87% vs NVO's -74.70%.

WW currently has the higher Sharpe Ratio (0.58 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WW and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer